Diferencia entre revisiones de «Lidocaine»

Sin resumen de edición
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(No se muestran 37 ediciones intermedias de 10 usuarios)
Línea 1: Línea 1:
''See [[critical care quick reference]] for drug doses by weight.''
==General==
==General==
*Also known internationally as lignocaine
*Type: [[Local anesthetics]]; [[Antiarrhythmics]]
*Type: [[Local anesthetics]]; [[Antiarrhythmics]]
*Dosage Forms:
*Dosage Forms: Local injection, transdermal, intravenous, inhaled, viscous
*Common Trade Names:  
*Common Trade Names: Xylocaine, P-Care, ReadySharp Lidocaine, Xylocard <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref>
 


==Adult Dosing==
===[[Local anesthetics|Local Anesthetic]]===
*Maximum without epinephrine: 5mg/kg (max 300mg)
*Maximum with epinepherine: 7mg/kg (max 500mg)


==Adult Dosing==
===[[Arrythmia|Antiarrhythmic]]===
===Local Anesthetic===
*Loading dose = 2% 1-1.5mg/kg
{{Maximum doses of anesthetic agents}}
**Additional boluses of 0.5-0.75mg/kg q5-10min up to max of 3mg/kg
===Antiarrhythmic===
*Loading dose = 1-1.5 mg/kg
**Additional boluses of 0.5-0.75 mg/kg q5-10min up to max of 3mg/kg
**If effective start infusion of 2mg/min
**If effective start infusion of 2mg/min
*Indications
*Indications
Línea 18: Línea 21:


==Pediatric Dosing==
==Pediatric Dosing==
===[[Local anesthetics|Local Anesthetic]]===
*Without epinepherine: 5mg/kg (max 300mg)
*With epinepherine: 7mg/kg (max 500mg)
===[[Arrythmia|Antiarrhythmic]]===
''See [[critical care quick reference]] for drug doses by weight.''


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: American B, Australia A
*Lactation:
*Lactation: Not expected to cause any adverse effect <ref>https://www.ncbi.nlm.nih.gov/books/NBK501230/</ref>
*Renal Dosing
*Renal Dosing
**Adult
**Adult: No adjustment provided in manufacturer's labelling but accumulation of metabolites may be increased in renal dysfunction<ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref>
**Pediatric
**Pediatric: No adjustment provided in manufacturer's labelling <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref>
*Hepatic Dosing
*Hepatic Dosing
**Adult
**Adult: Reduce maintenance infusion when used IV (0.75 mg/minute). Monitor concentration.<ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref>
**Pediatric
**Pediatric: Use with caution. Reduce dose. <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref>


==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to amide anesthetics
*High SA or AV block
**Note that these allergies are rare and are often caused by preservative, so a preservative-free formulation may be appropriate
**Note that allergy to amide anesthetics does not suggest allergy to ester anesthetics
*High SA or AV block (without pacemaker)
*Concurrent treatment with Class I anti-dysrhythmic agents
*[[Wolff-Parkinson-White syndrome]]


==Adverse Reactions==
==Adverse Reactions==
===Local===
*Dermatologic
**Itching or irritation
**Depigmentation
**Rash/urticaria
**Edema
**Venous inflammation
===Serious===
===Serious===
*[[Local Anesthetic Systemic Toxicity (LAST)]]
*[[Local Anesthetic Systemic Toxicity (LAST)]]
 
**Rare during infiltration of local anesthetic
===Common===
**CNS toxicity
***Metallic taste
***Tinnitus
***Tingling of lips
***Dizziness
***Anxiety
***Confusion
***Lethargy
***Loss of consciousness
***Seizures
***Nausea/vomiting
**Cardiovascular toxicity
***Bradycardia
***Decreased myocardial contractility
***Atrioventricular block
***Vasodilation
***Ventricular arrhythmias
***Cardiac arrest
*Bronchospasm
*Respiratory depression or arrest
*Methemoglobinemia


==Pharmacology==
==Pharmacology==
*Half-life:
*Pharmacokinetics
**Onset of action = 45-90s
**Onset of action = 45-90s
**Duration of action = 10-20min
**Duration of action = 10-20min (antiarrythmic IV); 30-90 min (subcutaneous)
*Metabolism:
**Half-life 90 - 120 minutes
*Excretion:
***Prolonged in hepatic impairment or congestive heart failure
*Mechanism of Action:
*Metabolism
**Primarily hepatic
*Excretion
**Urine
*Mechanism of Action
**Class Ib antiarrythmic
**Class Ib antiarrythmic
***Binds to fast Na channels in inactive state thereby inhibiting recovery after repolarization
***Binds to fast Na channels in inactive state thereby raising the depolarization threshold
***Acts preferentially on ischemic tissue
***Acts preferentially on ischemic tissue
****Elevates V-fib threshold
****Elevates V-fib threshold
****Suppresses ventricular ectopy
****Suppresses ventricular ectopy
**Little effect on vascular tone, contractility or cardiac output
**Little effect on vascular tone, contractility, or cardiac output


==Comments==
==Comments==
*For wounds, may use HCO3 (1cc to 10cc Lido) to decr pain  
*Mix lidocaine 1%/epinephrine with sodium bicarbonate 8.4% in 3:1 ratio results in significantly less painful injections. <ref>Vent A et. al Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial. J Am Acad Dermatol. 2020 Jul;83(1):159-165. doi: 10.1016/j.jaad.2019.09.088. https://pubmed.ncbi.nlm.nih.gov/31958526/ </ref> <ref>SGEM#307: Buff up the lido for the local anesthetic http://thesgem.com/2020/10/sgem307-buff-up-the-lido-for-the-local-anesthetic/</ref>
*inject through wound edges NOT intact skin
**Shorter shelf-life due to decreased stability (use within 2 hours in the Vent A study)
*Warming local anesthetics also decreases pain of injection <ref>Hogan, M., vanderVaart, S., Perampaladas, K., Machado, M., Einarson, T. and Taddio, A., 2020. Systematic Review And Meta-Analysis Of The Effect Of Warming Local Anesthetics On Injection Pain.</ref>
*Inject through wound edges whenever possible
**Avoid injecting through intact skin when possible
 
 
==Indications by Condition==
''The following table is automatically generated from disease/condition pages across WikEM.''
 
{{#ask:[[Has DrugName::Lidocaine]]
|?Has Indication=Indication
|?Has Dose=Dose
|?Has Context=Context
|?Has Route=Route
|?Has Population=Population
|format=table
|headers=plain
|mainlabel=-
|sort=Has Indication
|limit=50
}}


==See Also==
==See Also==
*[[Local Anesthetic Systemic Toxicity (LAST)]]
*[[Local anesthetic systemic toxicity]]
*[[Critical care quick reference]]
*[[Critical care quick reference]]


==Sources==
==References==
<references/>
<references/>


[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:Cards]]
[[Category:Cardiology]]
[[Category:Tox]]

Revisión actual - 21:56 20 mar 2026

See critical care quick reference for drug doses by weight.

General

  • Also known internationally as lignocaine
  • Type: Local anesthetics; Antiarrhythmics
  • Dosage Forms: Local injection, transdermal, intravenous, inhaled, viscous
  • Common Trade Names: Xylocaine, P-Care, ReadySharp Lidocaine, Xylocard [1]

Adult Dosing

Local Anesthetic

  • Maximum without epinephrine: 5mg/kg (max 300mg)
  • Maximum with epinepherine: 7mg/kg (max 500mg)

Antiarrhythmic

  • Loading dose = 2% 1-1.5mg/kg
    • Additional boluses of 0.5-0.75mg/kg q5-10min up to max of 3mg/kg
    • If effective start infusion of 2mg/min
  • Indications

Pediatric Dosing

Local Anesthetic

  • Without epinepherine: 5mg/kg (max 300mg)
  • With epinepherine: 7mg/kg (max 500mg)

Antiarrhythmic

See critical care quick reference for drug doses by weight.

Special Populations

  • Pregnancy Rating: American B, Australia A
  • Lactation: Not expected to cause any adverse effect [2]
  • Renal Dosing
    • Adult: No adjustment provided in manufacturer's labelling but accumulation of metabolites may be increased in renal dysfunction[3]
    • Pediatric: No adjustment provided in manufacturer's labelling [4]
  • Hepatic Dosing
    • Adult: Reduce maintenance infusion when used IV (0.75 mg/minute). Monitor concentration.[5]
    • Pediatric: Use with caution. Reduce dose. [6]

Contraindications

  • Allergy to amide anesthetics
    • Note that these allergies are rare and are often caused by preservative, so a preservative-free formulation may be appropriate
    • Note that allergy to amide anesthetics does not suggest allergy to ester anesthetics
  • High SA or AV block (without pacemaker)
  • Concurrent treatment with Class I anti-dysrhythmic agents
  • Wolff-Parkinson-White syndrome

Adverse Reactions

Local

  • Dermatologic
    • Itching or irritation
    • Depigmentation
    • Rash/urticaria
    • Edema
    • Venous inflammation

Serious

  • Local Anesthetic Systemic Toxicity (LAST)
    • Rare during infiltration of local anesthetic
    • CNS toxicity
      • Metallic taste
      • Tinnitus
      • Tingling of lips
      • Dizziness
      • Anxiety
      • Confusion
      • Lethargy
      • Loss of consciousness
      • Seizures
      • Nausea/vomiting
    • Cardiovascular toxicity
      • Bradycardia
      • Decreased myocardial contractility
      • Atrioventricular block
      • Vasodilation
      • Ventricular arrhythmias
      • Cardiac arrest
  • Bronchospasm
  • Respiratory depression or arrest
  • Methemoglobinemia

Pharmacology

  • Pharmacokinetics
    • Onset of action = 45-90s
    • Duration of action = 10-20min (antiarrythmic IV); 30-90 min (subcutaneous)
    • Half-life 90 - 120 minutes
      • Prolonged in hepatic impairment or congestive heart failure
  • Metabolism
    • Primarily hepatic
  • Excretion
    • Urine
  • Mechanism of Action
    • Class Ib antiarrythmic
      • Binds to fast Na channels in inactive state thereby raising the depolarization threshold
      • Acts preferentially on ischemic tissue
        • Elevates V-fib threshold
        • Suppresses ventricular ectopy
    • Little effect on vascular tone, contractility, or cardiac output

Comments

  • Mix lidocaine 1%/epinephrine with sodium bicarbonate 8.4% in 3:1 ratio results in significantly less painful injections. [7] [8]
    • Shorter shelf-life due to decreased stability (use within 2 hours in the Vent A study)
  • Warming local anesthetics also decreases pain of injection [9]
  • Inject through wound edges whenever possible
    • Avoid injecting through intact skin when possible


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Electrical storm1-1.5mg/kg IV bolus, then 1-4mg/min infusionAntiarrhythmic if actively ischemicIVAdult
Polymorphic ventricular tachycardia1-1.5mg/kg IV, then 1-4mg/min infusionNon-torsades PMVT, alternative agentIVAdult
Polymorphic ventricular tachycardia1mg/kg (max 100mg) IVNon-torsades PMVTIVPediatric
Pulseless arrest1-1.5 mg/kg, then 0.5-0.75 mg/kg q5-10 min2nd line antiarrhythmicIVAdult
Rapid sequence intubation1.5 mg/kgPremedicationIVAdult

See Also

References

  1. ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
  2. ↑ https://www.ncbi.nlm.nih.gov/books/NBK501230/
  3. ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
  4. ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
  5. ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
  6. ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
  7. ↑ Vent A et. al Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial. J Am Acad Dermatol. 2020 Jul;83(1):159-165. doi: 10.1016/j.jaad.2019.09.088. https://pubmed.ncbi.nlm.nih.gov/31958526/
  8. ↑ SGEM#307: Buff up the lido for the local anesthetic http://thesgem.com/2020/10/sgem307-buff-up-the-lido-for-the-local-anesthetic/
  9. ↑ Hogan, M., vanderVaart, S., Perampaladas, K., Machado, M., Einarson, T. and Taddio, A., 2020. Systematic Review And Meta-Analysis Of The Effect Of Warming Local Anesthetics On Injection Pain.
Obtenido de «https://www.wikem.org/w/index.php?title=Lidocaine&oldid=387463»